MYC and neoplasm: Moreover, through the use of targeted next-generation sequencing panels performed on a cohort of 113 tumor and 69 normal samples obtained from 92 high-grade OS patients as well as on a validation cohort of 86 patients, Marinoff et al. proved that MYC amplification is associated with a significant worse 3-year overall survival [60].